Hitachi plans U.S. MRI laboratory
Citing continued strong sales, Hitachi Medical Systems Americahas announced plans to establish an MRI research and developmentlaboratory at its U.S. headquarters in Twinsburg, OH. The group will develop new technologies, advanced clinicalapplications,
Citing continued strong sales, Hitachi Medical Systems Americahas announced plans to establish an MRI research and developmentlaboratory at its U.S. headquarters in Twinsburg, OH.
The group will develop new technologies, advanced clinicalapplications, and hardware and software enhancements, accordingto Sheldon Schaffer, HMSA vice president of marketing. Researchwill involve superconducting and permanent magnet technologies.
The company will recruit five engineers to staff the new facility,which will complement Hitachi's existing R&D operations inJapan.
HMSA, a joint venture between Hitachi and Summit World Trade,sells Hitachi MRI systems in the U.S.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
